ECSP034599A - TREATMENT OF ANXIETY DISORDERS - Google Patents

TREATMENT OF ANXIETY DISORDERS

Info

Publication number
ECSP034599A
ECSP034599A ECSP034599A ECSP034599A EC SP034599 A ECSP034599 A EC SP034599A EC SP034599 A ECSP034599 A EC SP034599A EC SP034599 A ECSP034599 A EC SP034599A
Authority
EC
Ecuador
Prior art keywords
treatment
anxiety disorders
medicament
manufacture
provides
Prior art date
Application number
Other languages
Spanish (es)
Inventor
David Michelson
Holly Read Thomasson
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ECSP034599A publication Critical patent/ECSP034599A/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención proporciona el uso de un inhibidor selectivo de la recaptación de norepinefrina con el fin de fabricar un medicamento para el tratamiento de trastornos de ansiedad.The present invention provides the use of a selective norepinephrine reuptake inhibitor in order to manufacture a medicament for the treatment of anxiety disorders.

ECSP034599 2000-11-15 2003-05-13 TREATMENT OF ANXIETY DISORDERS ECSP034599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US26536200P 2000-11-15 2000-11-15

Publications (1)

Publication Number Publication Date
ECSP034599A true ECSP034599A (en) 2003-06-25

Family

ID=40418785

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP034599 ECSP034599A (en) 2000-11-15 2003-05-13 TREATMENT OF ANXIETY DISORDERS

Country Status (1)

Country Link
EC (1) ECSP034599A (en)

Similar Documents

Publication Publication Date Title
AR037109A1 (en) USE OF FLIBANSERINE
HN2002000030A (en) NEW SUCCINATE SALT OF O-DESMETIL-VENLAFAXINA
ECSP17046065A (en) CRYSTALLINE FORMS OF (-) - (1R, 2R) -3- (3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL) -PHENOLHYDROCHLORIDE (DIVISIONAL APPLICATION)
AR048833A1 (en) PROCEDURE FOR THE TREATMENT OF PREMENSTRUAL DISORDERS AND OTHER FEMALE SEXUAL DISORDERS
MXPA05011208A (en) USE OF IVERMECTINE FOR THE TREATMENT OF DERMATOLOGICAL DISORDERS.
GT200100152A (en) NEW PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF OBESITY.
HN2002000275A (en) DERIVATIVES OF 1.8 NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
CR7583A (en) NEW VENLAFAXINA O-DESMETIL FORMAMATE SALT
CL2007002380A1 (en) Use of compounds derived from 2,5-dihydroxybenzene for the therapeutic and / or prophylactic treatment of actinic keratosis.
BR0114903A (en) 7-azaindoles, their application as phosphodiesterase 4 inhibitors and processes for their preparation
AR047553A1 (en) THE COMBINATION OF A SEROTONINE AND AGOMELATINE REABSORTION INHIBITOR
NO20043124L (en) Aminoindane derivatives such as serotonin and norepinephrine uptake inhibitors
ECSP045145A (en) USE OF NOREPINEFRINE RECAPTATION INHIBITORS FOR THE COGNITIVE FAILURE TREATMENT
BR0115301A (en) Use of a selective norepinephrine reuptake inhibitor
UY29790A1 (en) DIARILOIMIDAZOLA-4-CARBOXAMID SALTS, COMPOSITIONS THAT CONTAIN THEM, PREPARATION PROCESSES AND APPLICATIONS
UY29741A1 (en) SALTS OF 1,5- DIARIL PIRAZOL-3-CARBOXAMIDS, PREPARATION PROCESSES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, APPLICATIONS AND METHODS OF USE.
ECSP034599A (en) TREATMENT OF ANXIETY DISORDERS
PT1268482E (en) PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA
BRPI0409175A (en) oral pharmaceutical preparation for proton pumping antagonists
DK1455770T3 (en) Use of norepinephrine uptake inhibitors for the treatment of tic disorders
AR036886A1 (en) PROCESS TO PREPARE AN ELEMENT IN THE FORM OF GEL AND DEVICE FOR PURIFYING THE AIR.
BRPI0416202A (en) phosphodiesterase inhibitor formulations v
UY28111A1 (en) NEW ORAL IMMEDIATE RELEASE DOSAGE FORM
EA200600531A1 (en) COMBINATION OF SEROTONIN AND LOXAPINE REVERSE CAPTURE INHIBITOR
HN2001000119A (en) S-METHYL-DIHYDRO-ZIPRASIDONE FOR THE TREATMENT OF PSYCHIATRIC AND EYE DISORDERS.